Currently out of the existing stock ratings of Kelechi Chikere, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).

Kelechi Chikere

Work Performance Price Targets & Ratings Chart

Analyst Kelechi Chikere, carries an average stock price target met ratio of 38.89% that have a potential upside of 51.7% achieved within 41 days.

Kelechi Chikere’s has documented 19 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ALT, Altimmune at 30-Dec-2021.

Wall Street Analyst Kelechi Chikere

Analyst best performing recommendations are on ALT (ALTIMMUNE).
The best stock recommendation documented was for ALT (ALTIMMUNE) at 12/23/2020. The price target of $24 was fulfilled within 56 days with a profit of $11.38 (90.17%) receiving and performance score of 16.1.

Average potential price target upside

ALT Altimmune NVAX Novavax VAXX Vaxxinity

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Jul-2020

$14

$10.49 (298.86%)

$15

4 months 6 days ago
(07-Nov-2025)

0/16 (0%)

$9.89 (240.63%)

Buy Since 02-Jun-2021

$12

$8.49 (241.88%)

$12

4 months 21 days ago
(20-Oct-2025)

0/21 (0%)

$8 (200.00%)

Buy Since 25-Sep-2020

$18

$14.49 (412.82%)

$20

7 months ago
(13-Aug-2025)

4/17 (23.53%)

$14.26 (381.28%)

214

Buy Since 12-Nov-2024

$26

7 months ago
(13-Aug-2025)

0/1 (0%)

$16.51 (173.97%)

Buy Since 01-Jun-2020

$25

$21.49 (612.25%)

$25

1 years 8 months 20 days ago
(21-Jun-2024)

3/15 (20%)

$18.59 (290.02%)

42

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Kelechi Chikere?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?